Brief: Foghorn Therapeutics Provides Third Quarter Financial Results

Foghorn Therapeutics

08/11/2022 12:35

Nov 8 (Reuters) - Foghorn Therapeutics Inc.  FHTX.O :
    * FOGHORN THERAPEUTICS PROVIDES THIRD QUARTER 2022 FINANCIAL
AND
CORPORATE UPDATE
    * FOGHORN THERAPEUTICS .- CASH, CASH EQUIVALENTS &
MARKETABLE
SECURITIES OF $373.5 MILLION, AS OF SEPT 30, PROVIDES
SIGNIFICANT CASH RUNWAY INTO 2025
    * QTRLY LOSS PER SHARE $0.62
    * Q3 EARNINGS PER SHARE VIEW $-0.62, REVENUE VIEW $9.2
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX68Lz8n 
Further company coverage:  FHTX.O 
 ((Reuters.Briefs@thomsonreuters.com;))